Literature DB >> 20801567

Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort.

Robert D Toto1, Tom Greene, Lee A Hebert, Leena Hiremath, Janice P Lea, Julia B Lewis, Velvie Pogue, Mohammed Sika, Xuelei Wang.   

Abstract

BACKGROUND: Few studies have examined the association between obesity and markers of kidney injury in a chronic kidney disease population. We hypothesized that obesity is independently associated with proteinuria, a marker of chronic kidney disease progression. STUDY
DESIGN: Observational cross-sectional analysis. SETTING & PARTICIPANTS: Post hoc analysis of baseline data for 652 participants in the African American Study of Kidney Disease (AASK). PREDICTORS: Obesity, determined using body mass index (BMI). MEASUREMENTS & OUTCOMES: Urine total protein-creatinine ratio and albumin-creatinine ratio measured in 24-hour urine collections.
RESULTS: AASK participants had a mean age of 60.2 ± 10.2 years and serum creatinine level of 2.3 ± 1.5 mg/dL; 61.3% were men. Mean BMI was 31.4 ± 7.0 kg/m(2). Approximately 70% of participants had a daily urine total protein excretion rate <300 mg/d. In linear regression analyses adjusted for sex, each 2-kg/m(2) increase in BMI was associated with a 6.7% (95% CI, 3.2-10.4) and 9.4% (95% CI, 4.9-14.1) increase in urine total protein-creatinine and urine albumin-creatinine ratios, respectively. In multivariable models adjusting for age, sex, systolic blood pressure, serum glucose level, uric acid level, and creatinine level, each 2-kg/m(2) increase in BMI was associated with a 3.5% (95% CI, 0.4-6.7) and 5.6% (95% CI, 1.5-9.9) increase in proteinuria and albuminuria, respectively. The interaction between older age and BMI was statistically significant, indicating that this relationship was driven by younger AASK participants. LIMITATIONS: May not generalize to other populations; cross-sectional analysis precludes statements regarding causality.
CONCLUSIONS: BMI is associated independently with urine total protein and albumin excretion in African Americans with hypertensive nephrosclerosis, particularly in younger patients.
Copyright © 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20801567      PMCID: PMC4517588          DOI: 10.1053/j.ajkd.2010.05.016

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  34 in total

1.  Gender-specific reference value of urine albumin-creatinine ratio in healthy Chinese adults: results of the Beijing CKD survey.

Authors:  Rong Xu; Luxia Zhang; Puhong Zhang; Fang Wang; Li Zuo; Ying Zhou; Ying Shi; Gang Li; Shufang Jiao; Zejun Liu; Guobin Xu; Wannian Liang; Haiyan Wang
Journal:  Clin Chim Acta       Date:  2008-09-10       Impact factor: 3.786

Review 2.  Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?

Authors:  Richard J Johnson; Mark S Segal; Titte Srinivas; Ahsan Ejaz; Wei Mu; Carlos Roncal; Laura G Sánchez-Lozada; Michael Gersch; Bernardo Rodriguez-Iturbe; Duk-Hee Kang; Jaime Herrera Acosta
Journal:  J Am Soc Nephrol       Date:  2005-04-20       Impact factor: 10.121

3.  Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial.

Authors:  Lawrence J Appel; Catherine M Champagne; David W Harsha; Lawton S Cooper; Eva Obarzanek; Patricia J Elmer; Victor J Stevens; William M Vollmer; Pao-Hwa Lin; Laura P Svetkey; Sarah W Stedman; Deborah R Young
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

4.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Authors:  L Y Agodoa; L Appel; G L Bakris; G Beck; J Bourgoignie; J P Briggs; J Charleston; D Cheek; W Cleveland; J G Douglas; M Douglas; D Dowie; M Faulkner; A Gabriel; J Gassman; T Greene; Y Hall; L Hebert; L Hiremath; K Jamerson; C J Johnson; J Kopple; J Kusek; J Lash; J Lea; J B Lewis; M Lipkowitz; S Massry; J Middleton; E R Miller; K Norris; D O'Connor; A Ojo; R A Phillips; V Pogue; M Rahman; O S Randall; S Rostand; G Schulman; W Smith; D Thornley-Brown; C C Tisher; R D Toto; J T Wright; S Xu
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

5.  Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study.

Authors:  Zhongxin Zhang; Shahnaz Shahinfar; William F Keane; Denise Ramjit; Tania Z Dickson; Gilbert W Gleim; Carl Erik Mogensen; Dick de Zeeuw; Barry M Brenner; Steven M Snapinn
Journal:  J Am Soc Nephrol       Date:  2005-05-04       Impact factor: 10.121

6.  Prevalence and factors associated with CKD: a population study from Beijing.

Authors:  LuXia Zhang; PuHong Zhang; Fang Wang; Li Zuo; Ying Zhou; Ying Shi; Gang Li; ShuFang Jiao; ZeJun Liu; WanNian Liang; HaiYan Wang
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

7.  Obesity-related glomerulopathy in China: a case series of 90 patients.

Authors:  Hui-Mei Chen; Shi-Jun Li; Hui-Ping Chen; Qing-Wen Wang; Lei-Shi Li; Zhi-Hong Liu
Journal:  Am J Kidney Dis       Date:  2008-04-18       Impact factor: 8.860

8.  Waist-to-hip ratio, body mass index, and subsequent kidney disease and death.

Authors:  Essam F Elsayed; Mark J Sarnak; Hocine Tighiouart; John L Griffith; Tobias Kurth; Deeb N Salem; Andrew S Levey; Daniel E Weiner
Journal:  Am J Kidney Dis       Date:  2008-05-29       Impact factor: 8.860

9.  Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease.

Authors:  Melania Manco; Paolo Ciampalini; Rita DeVito; Andrea Vania; Marco Cappa; Valerio Nobili
Journal:  Pediatr Nephrol       Date:  2009-02-26       Impact factor: 3.714

10.  Clinical factors associated with urinary albumin excretion in type II diabetes.

Authors:  S Savage; N J Nagel; R O Estacio; N Lukken; R W Schrier
Journal:  Am J Kidney Dis       Date:  1995-06       Impact factor: 8.860

View more
  20 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

Review 3.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

4.  Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK).

Authors:  Teresa K Chen; Michelle M Estrella; Brad C Astor; Tom Greene; Xuelei Wang; Morgan E Grams; Lawrence J Appel
Journal:  Nephrol Dial Transplant       Date:  2015-03-27       Impact factor: 5.992

Review 5.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

6.  GFR estimation in the morbidly obese pre- and postbariatric surgery: one size does not fit all.

Authors:  Samra Abouchacra; Ahmed Chaaban; Nicole Gebran; Qutaiba Hussein; Mohamad Ahmed; Bassam Bernieh; Fowaz Torab; Yasser Kayyal; Hanan Al Omary; Nico Nagelkerke
Journal:  Int Urol Nephrol       Date:  2012-03-03       Impact factor: 2.370

7.  Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension.

Authors:  Stephen P Juraschek; Lawrence J Appel; Edgar R Miller
Journal:  Am J Hypertens       Date:  2017-09-01       Impact factor: 2.689

8.  Association of filtered sodium load with medullary volumes and medullary hypoxia in hypertensive African Americans as compared with whites.

Authors:  Stephen C Textor; Monika L Gloviczki; Michael F Flessner; David A Calhoun; James Glockner; Joseph P Grande; Michael A McKusick; Stephen S Cha; Lilach O Lerman
Journal:  Am J Kidney Dis       Date:  2011-11-29       Impact factor: 8.860

9.  Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.

Authors:  Shengyuan Luo; Josef Coresh; Adrienne Tin; Casey M Rebholz; Teresa K Chen; Salim S Hayek; Melissa Tracy; Michael S Lipkowitz; Lawrence J Appel; Andrew S Levey; Lesley A Inker; Jochen Reiser; Morgan Erika Grams
Journal:  Clin J Am Soc Nephrol       Date:  2018-06-14       Impact factor: 8.237

10.  Association of kidney disease with prevalent gout in the United States in 1988-1994 and 2007-2010.

Authors:  Stephen P Juraschek; Lara C Kovell; Edgar R Miller; Allan C Gelber
Journal:  Semin Arthritis Rheum       Date:  2013-01-09       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.